Skip to main content
SpringerLink
Log in

Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma: Improvements Needed in Population-Based Registries

  • Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Management of patients with borderline resectable/locally advanced (BR/LA) pancreatic adenocarcinoma is based on knowledge of natural history and patterns of treatment failure, information of great importance to large data registries. Using the SEER database, we examined the survival for patients with BR/LA tumors and critically evaluated the utility of the data.

Methods

T3/T4 tumors from 2004 to 2007 were divided into those that involved the portal vein/superior mesenteric vein/gastroduodenal artery/hepatic artery and those that involved the superior mesenteric artery (SMA) or celiac axis. The control group (CG) included patients who were recommended surgery but did not undergo it. Multivariate disease-specific survival analyses were performed using the Cox proportional hazards model.

Results

Of 3,837 patients, 571 patients (15 %) were recommended surgery, and 323 (8 %) underwent surgical resection. We were unable to separate patients into BR/LA based on current NCCN guidelines. We were able to identify vascular involvement but not those who actually underwent vascular resection. Median survival of patients who underwent surgery with SMA and celiac involvement was 12 and 8 months compared with 7 and 6 months, respectively, in the CG (p = .01). Patients who underwent surgical resection with venous involvement had a longer survival than those with arterial involvement (18 vs 12 months, p = .001).

Conclusions

Analysis of patients with BR/LA pancreatic adenocarcinoma who underwent pancreatic resection in the SEER database yielded limited information. New manuals must focus on obtaining information consistent with current advances in the field; our recommendations for optimizing the SEER database are included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10–15.

    Article  PubMed  Google Scholar 

  2. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004;198:722–31.

    Article  PubMed  Google Scholar 

  3. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74–85.

    Article  PubMed  Google Scholar 

  4. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456–62.

    Article  PubMed  Google Scholar 

  5. Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26:3496–502.

    Article  PubMed  CAS  Google Scholar 

  6. Evans DB, Erickson BA, Ritch P. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol. 2010;17:2803–5.

    Article  PubMed  Google Scholar 

  7. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–46.

    Article  PubMed  Google Scholar 

  8. Evans DB, Farnell MB, Lillemoe KD, Vollmer C Jr, Strasberg SM, Schulick RD. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1736–44.

    Article  PubMed  Google Scholar 

  9. Katz MH, Pisters PW, Evans DB, et al. (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 206:833–46 (Discussion 846–8).

    Article  PubMed  Google Scholar 

  10. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–13.

    PubMed  CAS  Google Scholar 

  11. Allendorf JD, Lauerman M, Bill A, et al. Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. J Gastrointest Surg. 2008;12:91–100.

    Article  PubMed  Google Scholar 

  12. Al-Haddad M, Martin JK, Nguyen J, et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg. 2007;11:1168–74.

    Article  PubMed  Google Scholar 

  13. Bold RJ, Charnsangavej C, Cleary KR, et al. Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg. 1999;3:233–43.

    Article  PubMed  CAS  Google Scholar 

  14. Carrere N, Sauvanet A, Goere D, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006;30:1526–35.

    Article  PubMed  Google Scholar 

  15. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric–portal vein confluence. Pancreatic tumor study group. Ann Surg. 1996;223:154–62.

    Article  PubMed  CAS  Google Scholar 

  16. Illuminati G, Carboni F, Lorusso R, et al. Results of a pancreatectomy with a limited venous resection for pancreatic cancer. Surg Today. 2008;38:517–23.

    Article  PubMed  Google Scholar 

  17. Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg. 2009;75:804–9 (Discussion 809–10).

    PubMed  Google Scholar 

  18. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8:935–49 (Discussion 949–50).

    Article  PubMed  Google Scholar 

  19. Nakao A, Takeda S, Inoue S, et al. (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg. 30:976–82.

    Article  PubMed  Google Scholar 

  20. Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach. Surgery. 1973;73:307–20.

    PubMed  CAS  Google Scholar 

  21. Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977;186:42–50.

    Article  PubMed  CAS  Google Scholar 

  22. Bachellier P, Rosso E, Lucescu I, et al. Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol. 2011;103:75–84.

    Article  PubMed  Google Scholar 

  23. Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas EF, Izbicki JR. Arterial en bloc resection for pancreatic carcinoma. Br J Surg. 2011;98:86–92.

    Article  PubMed  CAS  Google Scholar 

  24. Hirano S, Kondo S, Hara T, et al. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg. 2007;246:46–51.

    Article  PubMed  Google Scholar 

  25. Stitzenberg KB, Watson JC, Roberts A, et al. Survival after pancreatectomy with major arterial resection and reconstruction. Ann Surg Oncol. 2008;15:1399–406.

    Article  PubMed  Google Scholar 

  26. Yekebas EF, Bogoevski D, Cataldegirmen G, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg. 2008;247:300–9.

    Article  PubMed  Google Scholar 

  27. Wu X, Tao R, Lei R, et al. Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol. 2010;17:1359–66.

    Article  PubMed  Google Scholar 

  28. Amano H, Miura F, Toyota N, et al. Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer? J Hepatobiliary Pancreat Surg. 2009;16:850–7.

    Article  PubMed  Google Scholar 

  29. Wu YL, Yan HC, Chen LR, Gao SL, Chen J, Dong X. (2007) Extended Appleby’s operation for pancreatic cancer involving celiac axis. J Surg Oncol. 96:442–6 (Discussion 447).

    Article  PubMed  Google Scholar 

  30. Chua TC, Saxena A. Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg. 2010;14:1442–52.

    Article  PubMed  Google Scholar 

  31. Martin RC 2nd, Scoggins CR, Egnatashvili V, Staley CA, McMasters KM, Kooby DA. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg. 2009;144:154–9.

    Article  PubMed  Google Scholar 

  32. Mollberg N, Rahbari NN, Koch M, et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011;254:882–93.

    Article  PubMed  Google Scholar 

  33. Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL. (2002) En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg. 6:147–57 (Discussion 157–8).

    Article  PubMed  Google Scholar 

  34. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. http://www.seer.cancer.gov. Accessed 13 June 2012.

  35. National Comprehensive Cancer Network. Pancreatic Adenocarcinoma (Version 2.2012) March 29, 2012. http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed 13 June 2012.

  36. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60.

    Article  PubMed  Google Scholar 

  37. Katz MH, Varadhachary GR, Fleming JB, et al. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol. 2010;17:1794–801.

    Article  PubMed  Google Scholar 

Download references

Disclosure

There are no financial disclosures from any of the authors and this study has no funding source

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USA

    John T. Miura MD, Douglas B. Evans MD, Sam G. Pappas MD, FACS, T. Clark Gamblin MD, MS, FACS & Kiran K. Turaga MD, MPH

Authors
  1. John T. Miura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas B. Evans MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sam G. Pappas MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Clark Gamblin MD, MS, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiran K. Turaga MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiran K. Turaga MD, MPH.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 38 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miura, J.T., Evans, D.B., Pappas, S.G. et al. Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma: Improvements Needed in Population-Based Registries. Ann Surg Oncol 20, 4338–4347 (2013). https://doi.org/10.1245/s10434-013-3237-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3237-6

Keywords

Search

Navigation